BERLIN — A novel investigational ileal bile acid transporter (IBAT) inhibitor, linerixibat, significantly and rapidly reduced cholestatic pruritus in patients with primary biliary cholangitis (PBC), ...

The special video shows that the love of the "Peanuts" gang has made it through generations of the Schulz family Charles M. Schulz Museum/Instagram; Alamy It has been 75 years since the "Peanuts" ...

Isaac "Pitbull" Cruz will welcome Lamont Roach to the super lightweight division. The former Gervonta "Tank" Davis opponents will square off for the WBC interim title on Dec. 6 at the Frost Bank ...

Greptile, a startup that’s building artificial intelligence-based code reviewers to validate human- and AI-generated software, has raised $25 million in an early-stage round of funding as it looks to ...

Anthropic PBC’s premium prices for its AI tools may not be sustainable in the long run because of increasing competition, according to a report by JPMorgan Chase & Co. that initiated analyst coverage ...

A woman was killed while sleeping underneath a box trailer of a landscaping truck. Former Stuart city manager speaks for first time since removal Former Stuart City Manager Mike Mortell is speaking ...

Please provide your email address to receive an email when new articles are posted on . Intercept has voluntarily withdrawn its lone product, Ocaliva, from U.S. market for primary biliary cholangitis.

OpenAI announced Thursday it reached a nonbinding agreement with Microsoft, its largest investor, on a revised partnership that would allow the startup to convert its for-profit arm into a public ...

Intercept Pharmaceuticals has voluntarily withdrawn Ocaliva (obeticholic acid) for the treatment of primary biliary cholangitis (PBC) from the US market. The decision follows a request from the FDA.

IF THERE’S A SPECIFIC BRAND THAT YOU’RE LOOKING FOR. WELL, WITH ALMOST $1 MILLION IN FUNDING TO WORK WITH A LOCAL ZOO IS MAKING SOME BIG CHANGES, FROM CLEANER WATER TO RESTORED WETLANDS. THE GOAL IS A ...

Zydus Therapeutics has racked up a phase 2b/3 win in primary biliary cholangitis (PBC), clearing the path to a filing to establish the company as a challenger to Gilead Sciences, Intercept ...

Founded by former OpenAI staff members and funded by Amazon and Google, Anthropic has raised the stakes in the GPT wars. Anthropic's Claude Desktop app often outshines its ChatGPT rival in various ...